Healthtech Startups
16,916 companies tagged Healthtech, with their investors and founders.
Alithea Genomics develops RNA sequencing technologies and platforms that enable pharmaceutical, agritech, cosmetics, and academic teams to generate large-scale transcriptomic datasets for compound screening, crop engineering, and ingredient development. The company's plate-based, high-throughput solutions reduce costs, hands-on time, and environmental impact compared to standard RNA-seq practices.
2 investors
Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.
2 investors
all.health offers an Integrated Continuous Management (ICM) platform combining a clinical-grade wearable with an FDA-recognized system that collects 24/7 vitals and biometrics, screens for disease risk, and links patients to their care teams. It partners with health systems to integrate continuous remote monitoring into clinical workflows and provides AI-driven insights for clinicians.
2 investors
Allevi, part of 3D Systems, makes desktop 3D bioprinters and bioinks used by academic and industry research labs to design and engineer 3D tissues. Its tools support work in regenerative medicine, drug testing, and disease research.
2 investors
Allia Health offers an electronic health record (EHR) platform for behavioral health practices, combining intake, scheduling, documentation, prescribing, and billing in one system. It includes an AI scribe that transcribes visits and drafts structured clinical notes, and serves solo practitioners, group practices, and multi-site providers across the US.
2 investors
ALLInBio develops a precision immunology approach to identify and treat patients genetically predisposed to rapid progression of chronic inflammatory diseases. The platform shifts treatment from symptom management to early intervention in at-risk populations.
2 investors
Allorion Therapeutics is a biotech company developing next-generation targeted small-molecule drugs for human diseases, using data-driven discovery platforms and partnerships with pharmaceutical companies for commercialization.
2 investors
Alpha Tau Medical develops Alpha DaRT, a technology platform for cancer treatment using targeted alpha radiation therapy across multiple cancer types including skin, pancreatic, brain, lung, and prostate cancers at various clinical stages.
2 investors
AlphaNavi Pharma is a pharmaceutical company developing new drugs (Nav channel inhibitors) for patients suffering from chronic pain and neurological disorders. It conducts in-house research and development in collaboration with academia, companies, and investors in Japan and abroad.
2 investors
Alpheus is a clinical-stage biotechnology company developing Porphyrin Metabolite Activation (PoMAβ’), a drug-led oncology approach designed to treat glioblastoma using proprietary low-intensity ultrasound to activate tumor-localized porphyrin metabolites. The company's lead program is in a randomized Phase 2b trial for newly diagnosed glioblastoma.
2 investors
Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27β51 months to as little as 18 months. The company serves biotech sponsors developing small molecules, monoclonal antibodies, and emerging modalities through parallel workstreams across all development phases.
2 investors
Alteon Health is a physician-owned and physician-led acute care medical group that partners with hospitals and health systems to provide hospitalist medicine, post-acute care, and clinical staffing. Serving patients across 17 US states, it employs physicians and advanced practice providers (APPs) and supports them with data, administrative services, and professional development.
2 investors
Alvee is a software platform that identifies social and health barriers from clinical notes, automates patient outreach and follow-up, and generates compliant billing documentation for care coordination and navigation services in healthcare settings. It helps health systems and FQHCs capture reimbursable revenue from Medicare and Medicaid codes for care coordination, navigation, and social needs interventions.
2 investors
Amara offers wellness programming β group classes and 1:1 sessions in physical, social, and mental wellness β led by physical therapists, occupational therapists, and trainers. It delivers these services to residents at properties, often paid for by property managers, and provides an online platform for booking classes and tracking progress, currently operating in Chicago and Los Angeles.
2 investors
Amby is an AI coaching app that delivers personalized training plans via text messages, integrating data from Strava, Garmin, and Apple Health to provide proactive check-ins and coaching for endurance athletes. The service focuses on recovery monitoring, training load management, and athlete guidance without requiring a dedicated app interface or new hardware.
2 investors
Amera Health Solutions provides a data integration platform that connects fragmented claims processing systems for health plans. The platform ingests claims from multiple sources and converts them into standardized data, enabling automation and supporting modern benefit designs like direct primary care and reference-based pricing.
2 investors
American Vision Partners is a management organization supporting a network of ophthalmology and eye care practices, including Barnet Dulaney Perkins Eye Center, Southwest Eye Institute, and Retinal Consultants of Arizona. This page presents its National Medical Executive Committee of physicians and optometrists overseeing clinical care across affiliated eye centers in the U.S. Southwest.
2 investors
Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
2 investors
Amgen develops therapies based on biotechnology and scientific research aimed at treating patients and improving or saving lives. It operates in the biopharmaceutical industry, moving discoveries from the laboratory through clinical development to market.
2 investors
Amissa Health quantifies symptoms through wearable data and biometric collection to improve clinical care and research, with a focus on early detection of Alzheimer's and digital biomarkers for perimenopause in women. The company serves healthcare institutions, researchers, and patients seeking personalized treatment guidance.
2 investors
Amparo develops custom-fit prosthetic sockets for lower limb amputees, featuring a remoldable design that adapts to changes in the patient's residual limb. The company serves orthopaedic and prosthetic specialists across 30+ countries, enabling faster and more comfortable prosthetic fitting for post-amputation patients.
2 investors
AMPAworks builds supply chain and inventory management technology to help healthcare organizations improve operational efficiency and reduce costs. Its team of doctors, nurses, and engineers focuses on giving frontline workers the tools and supplies needed to care for patients.
2 investors
AmplifiDx develops point-of-care molecular diagnostic tests and its DX 100 platform for family, women's, and sexual health, targeting infectious disease detection for healthcare professionals and patients. The multiplex platform can detect up to 10 analytes with rapid results and minimal hands-on time.
2 investors
Amplifier Health provides a Voice Intelligence API that analyzes acoustic biomarkers from voice samples to enable non-invasive health screening. The platform is designed for clinical and healthcare applications, powered by a large acoustic health dataset validated with leading research institutions.
2 investors